Jump To Top

goodgameempireplay

albuterol for four year old

Depressive symptoms increased among seniors during COVID-19

(HealthDay)—During the COVID-19 pandemic, there was an increase in the prevalence of clinically significant depressive symptoms among older adults, according to a study published online Dec. 22 in JAMA Psychiatry.

Paola Zaninotto, bupropion sr shelf life Ph.D., from the University College London, and colleagues conducted a longitudinal cohort study involving data from 5,146 older adults participating in the English Longitudinal Study of Ageing. Participants provided data before the COVID-19 pandemic and on two occasions in 2020 (June or July and November or December).

The researchers observed an increase in the prevalence of clinically significant depressive symptoms from 12.5 percent before the COVID-19 pandemic to 22.6 and 28.5 percent in June and July and in November and December 2020, respectively. The increase was accompanied by increased loneliness and a decline in quality of life. From June and July 2020 to November and December 2020, the prevalence of anxiety increased from 9.4 to 10.9 percent. Worse changes in mental health were experienced by women and nonpartnered individuals. Before and during the COVID-19 pandemic, the lowest levels of mental health were seen for participants with less wealth. Better mental health overall was seen for higher socioeconomic groups, but they responded to the COVID-19 pandemic with more negative changes.

Source: Read Full Article